Involvement of asparatic acid racemization and isomerization in the pathogenesis of COPD

R. Koizumi, M. Ogasawara, N. Sasaki, T. Tanita, Y. Nakamura, K. Yamauchi (Morioka, Toon, Japan)

Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session: Translational studies in chronic lung diseases: from bedside to bench
Session type: Poster Discussion
Number: 246
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Koizumi, M. Ogasawara, N. Sasaki, T. Tanita, Y. Nakamura, K. Yamauchi (Morioka, Toon, Japan). Involvement of asparatic acid racemization and isomerization in the pathogenesis of COPD. Eur Respir J 2013; 42: Suppl. 57, 246

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013

LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD?
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014

Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Effect of antioxidants, L-2-oxothiazolidine-4-carboxylic acid and α-lipoic acid, on airway remodeling in chronic model of allergic airway disease
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Reduction of high mobility group nucleosome binding domain-5 protein promotes the development of emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014

Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015

The reactive carbonyl derivatives of proteins in neutrophils of patients with varying severity of COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Different response of lung tissue to intravenous acetylated opium
Source: International Congress 2015 – Different data in COPD
Year: 2015


Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


LSC 2014 abstract - The role of the formyl peptide receptor in the development of pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014

Prooxidant-antioxidant balance in mustard airway disease with different severity
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015


Local and systemic nucleic acid damage in COPD exacerbations.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017

Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016